Skip to main content

Acute Ischemic Stroke PICASSO

Status: Open to Enrollment
Email us to enroll

Study details

View study details on www.clinicaltrials.gov.

Locations

  • San Francisco
  • Sacramento

Clinical trial FAQs

Information for patients and study volunteers, including frequently asked questions.

Proximal Internal Carotid Artery Acute Stroke Secondary to Tandem or Local Occlusion Thrombectomy Trial (PICASSO).

The primary objective is to establish the efficacy of intra-arterial (IA) mechanical thrombectomy (MT) with extracranial proximal carotid artery acute stenting versus non-stenting approaches in patients with acute ischemic stroke (AIS) from intracranial vessel occlusion (IVO) in the anterior circulation and have a proximal carotid occlusive disease (occlusion or severe stenosis).

Fabio Settcase, M.D., M.S., FRCPC
Fabio Settcase, M.D., M.S., FRCPC
Principal investigator
View profile
Matthew D Alexander, M.D.
Matthew D Alexander, M.D.
Principal investigator
View profile

Related clinical trials

View all clinical trials
  • Clinical trial

    Stroke FASTEST

    Recombinant Factor VIIa (rFVIIa) for Acute Hemorrhagic Stroke Administered At Earliest Time (FASTEST) Trial

    Status: Open to Enrollment

  • Clinical trial

    ALS Healey Platform Trial Master Protocol

    HEALEY ALS Platform Trial

    Status: Closed to Enrollment

  • Clinical trial

    ALS SPG302 Expanded Access Protocol

    Intermediate-size Patient Population Expanded Access Protocol for SPG302 in Adult Patients With Amyotrophic Lateral Sclerosis (ALS)

    Status: Open to Enrollment

  • Clinical trial

    Amyotrophic Lateral Sclerosis (ALS) C302-CLN-2301

    Phase 2, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, 24-Week Study With Additional 24-Week Blinded Active Extension to Evaluate the Safety and Efficacy of COYA 302 for the Treatment of Amyotrophic Lateral Sclerosis (ALS)

    Status: Open to Enrollment

  • Clinical trial

    Amyotrophic Lateral Sclerosis (ALS) PL101-ALS301 PREVAILS

    A Phase 3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Pridopidine in Participants With Amyotrophic Lateral Sclerosis

    Status: Open to Enrollment

You're leaving our site

The website you have selected is an external one located on another server. This website may contain links to third party sites. These links are provided for convenience purposes and are not under the control of Sutter Health. Do you wish to continue?